v3.20.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 3,181 $ 1,338
Restricted cash 350
Trade receivables 103 111
Other accounts receivable and prepaid expenses 161 268
Inventory 109 121
Total current assets 3,904 1,838
Non-current assets:    
Fixed assets, net 2 4
Other assets 33
Severance pay fund 163 194
Total non-current assets 198 198
Total assets 4,102 2,036
Current liabilities:    
Trade payables 89 129
Other accounts payable and accrued expenses 261 280
Notes payable 14
Total current liabilities 364 409
Non-current liabilities:    
Accrued severance pay 228 279
Deferred licensing income 215
Notes payable, non-current 28
Total liabilities 835 688
Commitments and contingencies (Note 9)
Stockholders' equity:    
Common stock of $0.001 par value - Authorized: 20,000,000 shares at September 30, 2020 and December 31, 2019; Issued and outstanding: 12,493,653 and 4,203,764 shares at September 30, 2020 and December 31, 2019, respectively 12 5
Additional paid in capital 44,901 39,669
Accumulated deficit (41,650) (38,330)
Total stockholders' equity 3,267 1,348
Total liabilities and stockholders' equity 4,102 2,036
Series C Preferred Stock [Member]    
Stockholders' equity:    
Preferred stock value 2 2
Total stockholders' equity 2 2
Series D Preferred Stock [Member]    
Stockholders' equity:    
Preferred stock value
Total stockholders' equity
Series E Preferred Stock [Member]    
Stockholders' equity:    
Preferred stock value 2 2
Total stockholders' equity $ 2 $ 2

Source